FDA Approves Over-the-Counter Naloxone Nasal Spray

The FDA has approved the first over-the-counter (OTC) naloxone nasal spray — Emergent BioSolutions’ opioid overdose therapy Narcan, 4 mg — and is encouraging other producers to apply for OTC status.
Source: Drug Industry Daily